These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20108615)

  • 1. Study of a high-risk group of stage II colon cancer.
    Hirosawa T; Itabashi M; Bamba Y; Ogawa S; Sirotani N; Kameoka S
    Int Surg; 2009; 94(2):130-5. PubMed ID: 20108615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor budding as an index to identify high-risk patients with stage II colon cancer.
    Nakamura T; Mitomi H; Kanazawa H; Ohkura Y; Watanabe M
    Dis Colon Rectum; 2008 May; 51(5):568-72. PubMed ID: 18286339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
    Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM
    J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.
    O'Connell MJ; Campbell ME; Goldberg RM; Grothey A; Seitz JF; Benedetti JK; André T; Haller DG; Sargent DJ
    J Clin Oncol; 2008 May; 26(14):2336-41. PubMed ID: 18467725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer.
    Law CH; Wright FC; Rapanos T; Alzahrani M; Hanna SS; Khalifa M; Smith AJ
    J Surg Oncol; 2003 Nov; 84(3):120-6. PubMed ID: 14598354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors for recurrence of stage II colon cancer].
    Okamoto Y; Kawamura T; Sakai T; Mitsutsuji M; Oshikiri T; Kamoda Y; Takase N
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1633-7. PubMed ID: 21996958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of outcomes of emergency and elective surgeries for complicated colonic cancer.
    Biondo S; Martí-Ragué J; Kreisler E; Parés D; Martín A; Navarro M; Pareja L; Jaurrieta E
    Am J Surg; 2005 Apr; 189(4):377-83. PubMed ID: 15820446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
    Meyerhardt JA; Heseltine D; Niedzwiecki D; Hollis D; Saltz LB; Mayer RJ; Thomas J; Nelson H; Whittom R; Hantel A; Schilsky RL; Fuchs CS
    J Clin Oncol; 2006 Aug; 24(22):3535-41. PubMed ID: 16822843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and time interval from surgery to start of chemotherapy among colon cancer patients.
    Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS
    J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of histologic type of primary lesion and metastatic lymph nodes as a prognostic factor in stage III colon cancer.
    Mori T; Hirota T; Ohashi Y; Kodaira S;
    Dis Colon Rectum; 2006 Jul; 49(7):982-92. PubMed ID: 16625329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical volume influences survival in patients undergoing resections for stage II colon cancers.
    Morris M; Platell CF
    ANZ J Surg; 2007 Oct; 77(10):902-6. PubMed ID: 17803560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
    Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M
    Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer invasion to Auerbach's plexus is an important prognostic factor in patients with pT3-pT4 colorectal cancer.
    Fujita S; Nakanisi Y; Taniguchi H; Yamamoto S; Akasu T; Moriya Y; Shimoda T
    Dis Colon Rectum; 2007 Nov; 50(11):1860-6. PubMed ID: 17899273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases.
    Bowne WB; Lee B; Wong WD; Ben-Porat L; Shia J; Cohen AM; Enker WE; Guillem JG; Paty PB; Weiser MR
    Dis Colon Rectum; 2005 May; 48(5):897-909. PubMed ID: 15785892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of lymph node ratio as a prognostic marker in colon cancer.
    Derwinger K; Carlsson G; Gustavsson B
    Eur J Surg Oncol; 2008 Jul; 34(7):771-5. PubMed ID: 18079086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy as treatment of high-risk stage I and II endometrial cancer.
    Aoki Y; Watanabe M; Amikura T; Obata H; Sekine M; Yahata T; Fujita K; Tanaka K
    Gynecol Oncol; 2004 Aug; 94(2):333-9. PubMed ID: 15297170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
    van Geelen CM; Westra JL; de Vries EG; Boersma-van Ek W; Zwart N; Hollema H; Boezen HM; Mulder NH; Plukker JT; de Jong S; Kleibeuker JH; Koornstra JJ
    J Clin Oncol; 2006 Nov; 24(31):4998-5004. PubMed ID: 17075118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.